Antibody to combat coronavirus discovered by Israeli research group

Israel's Defense Ministry announced this groundbreaking discovery on Tuesday evening, providing the three key parameters discovered by the new development.

The first is the antibody monoclonal, new and refined, which contains an exceptionally low proportion of harmful proteins. The second is the ability of the antibody to neutralize the coronavirus, as demonstrated by the IIBR. Finally, the antibody was specifically tested on the aggressive coronavirus.

"Based on comprehensive scientific publications from around the globe, it appears that the IIBR is the first institution to achieve a scientific breakthrough that meets all three of the aforementioned parameters simultaneously. This is a result of the institute’s great experience and the unique capabilities of its scientists," stated Israel's Defense Ministry.

A patent for the new development is currently being pursued by the IIBR, from there they will make contact with various international manufacturers.

"It should be emphasized that this scientific achievement has the potential to progress towards a treatment for corona patients, and that it is not a vaccine for wide use. This is an important milestone, which will be followed by a series of complex tests and a process of regulatory approvals. This being said, the scientists at the institute believe that the nature of this breakthrough could lead to a shortening of the process, which could span over several months," concluded the Defense Ministry statement.